Breast cancer malignancy is governed by regulation of the macroH2A2/TM4SF1 axis, the AKT/NF‐κB pathway, and elevated MMP13 expression

Documenti analoghi

• CCNL1 Activates the NF‐κB Pathway Through DVL3 Inhibition and PI3K/AKT Pathway Promotion in Breast Cancer
  di: Dan Zhang, et al.
  Pubblicazione: (2026)
• Withaferin A Exerts Cytotoxicity in Single/Multidrug‐Resistant Gastric and Ovarian Cancer Cells and Tumor Xenografts Through the AKT–NF‐κB–STAT3–Survivin Axis
  di: Priti S. Shenoy, et al.
  Pubblicazione: (2025)
• STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β‐catenin signaling pathway
  di: Junyi Jin, et al.
  Pubblicazione: (2024)
• LAIR1 promotes hepatocellular carcinoma cell metastasis and induces M2‐macrophage infiltration through activating AKT‐IKKβ‐p65 axis
  di: Banglun Pan, et al.
  Pubblicazione: (2024)
• ABHD6 suppresses colorectal cancer progression via AKT signaling pathway
  di: Xiaoyu Xiong, et al.
  Pubblicazione: (2024)